IRVINE, CA – CG Oncology, Inc. (CGON), a biotechnology firm specializing in biological products with a market capitalization of $2.06 billion, announced on Thursday, January 9, 2025, that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback